Myomo (MYO) FCF Margin Growth (1y) (2017 - 2025)
Myomo (MYO) FCF Margin Growth (1y) (2017 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 184.21 Bn | 176.92 Bn | 6.27 Bn | -80.00 |
| 2 | Stryker | 128.90 Bn | 126.02 Bn | 3.81 Bn | 473.00 |
| 3 | Medtronic | 109.00 Bn | 99.78 Bn | 6.41 Bn | -192.00 |
| 4 | Boston Scientific | 68.62 Bn | 67.16 Bn | 3.61 Bn | -431.00 |
| 5 | Edwards Lifesciences | 47.39 Bn | 43.72 Bn | 1.29 Bn | -1,716.00 |
| 6 | GE HealthCare Technologies | 28.44 Bn | 26.16 Bn | 1.98 Bn | -125.00 |
| 7 | Dexcom | 28.39 Bn | 27.27 Bn | 750.30 Mn | 2,833.00 |
| 8 | Smith & Nephew | 27.03 Bn | 26.46 Bn | - | - |
| 9 | Koninklijke Philips | 25.55 Bn | 22.43 Bn | 2.07 Bn | 2,811.00 |
| 10 | Myomo | 42.89 Mn | 23.92 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -885.00 |
| Jun 30, 2025 | -7,781.00 |
| Mar 31, 2025 | 5,399.00 |
| Dec 31, 2024 | 7,095.00 |
| Sep 30, 2024 | 1,511.00 |
| Jun 30, 2024 | -2,202.00 |
| Mar 31, 2024 | -3,402.00 |
| Dec 31, 2023 | 1,086.00 |
| Sep 30, 2023 | 3,585.00 |
| Jun 30, 2023 | 6,840.00 |
| Mar 31, 2023 | 732.00 |
| Dec 31, 2022 | -1,463.00 |
| Sep 30, 2022 | -1,946.00 |
| Jun 30, 2022 | 4,253.00 |
| Mar 31, 2022 | 3,099.00 |
| Dec 31, 2021 | -1,612.00 |
| Sep 30, 2021 | 4,337.00 |
| Jun 30, 2021 | 30,973.00 |
| Mar 31, 2021 | 15,098.00 |
| Dec 31, 2020 | 14,448.00 |